Back to Search Start Over

Effects of Rhus coriaria L. hydroalcoholic extract on the lipid and antioxidant profile in high fat diet-induced hepatic steatosis in rats.

Authors :
Ghaeni Pasavei, Abdolmomen
Mohebbati, Reza
Jalili-Nik, Mohammad
Mollazadeh, Hamid
Ghorbani, Ahmad
Nosrati Tirkani, Abolfazl
Taraz Jamshidi, Shirin
Hashemy, Seyed Isaac
Heidarian Miri, Hamid
Soukhtanloo, Mohammad
Source :
Drug & Chemical Toxicology. Jan2021, Vol. 44 Issue 1, p75-83. 9p.
Publication Year :
2021

Abstract

Oxidative stress is related to increased fat deposition in the liver, known as hepatic steatosis. The present study is an evaluation of the anti-oxidative and antihyperlipidemic effects of the hydroalcoholic extract of Rhus coriaria L. (HARE) in rats on a high-fat diet (HFD). Twenty male Wistar rats were divided into four groups: control, HFD, HFD + HARE 50 mg/kg/day, and HFD + HARE 250 mg/kg/day for 12 weeks. Animals were weighed weekly and treated with the HARE extract for 12 weeks by gavage. Subsequently, the histopathological changes, oxidative markers, and lipid profile were evaluated. Statistical analysis was performed using the one-way analysis of variance (ANOVA) for multiple comparisons. First, the active ingredients of the extract were determined by HPLC. Then, the levels in the serum lipid profile (TG, cholesterol, HDL, and LDL) in rats fed with the HFD + HARE were analyzed where a significant reduction was observed. The HFD proved to increase the activity of the liver enzymes, the serum lipid levels, and the malondialdehyde (MDA) level. The ferric-reducing antioxidant activity power (FRAP), catalase (CAT), and superoxide dismutase (SOD) catalytic activity were reduced in the liver homogenate of HFD rats compared to the controls. Additionally, the aforementioned liver enzymes activities were reduced in response to HARE. Evaluation of oxidative stress determined a reduction in the MDA level while a raised FRAP was confirmed. In accordance with the present results, histopathological observations have also demonstrated that HARE ameliorated grade-1 hepatic steatosis induced by HFD. Taken together, the findings of this study introduce HARE as a future potential therapeutic agent in treating hepatic steatosis and reducing oxidative damages of an HFD in the liver. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01480545
Volume :
44
Issue :
1
Database :
Academic Search Index
Journal :
Drug & Chemical Toxicology
Publication Type :
Academic Journal
Accession number :
147626529
Full Text :
https://doi.org/10.1080/01480545.2018.1533024